Phase 2 randomized placebo‐controlled study of lasmiditan for the acute treatment of migraine in Japanese patients

OBJECTIVE: To evaluate the efficacy and safety of lasmiditan in Japanese adults with migraine. BACKGROUND: Global clinical studies have demonstrated the efficacy and safety of lasmiditan in the acute treatment of migraine. METHODS: This was a multicenter, randomized, double‐blind, placebo‐controlled...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakai, Fumihiko, Takeshima, Takao, Homma, Gosuke, Tanji, Yuka, Katagiri, Hideaki, Komori, Mika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Submissions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252620/
https://www.ncbi.nlm.nih.gov/pubmed/33990951
http://dx.doi.org/10.1111/head.14122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252620/
https://www.ncbi.nlm.nih.gov/pubmed/33990951
http://dx.doi.org/10.1111/head.14122

Ejemplares similares